The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 30, 2025
Filed:
Oct. 28, 2019
Applicant:
Senju Pharmaceutical Co., Ltd., Osaka, JP;
Inventors:
Yayoi Kishimoto, Osaka, JP;
Chiho Yabuta, Osaka, JP;
Assignee:
SENJU PHARMACEUTICAL CO., LTD., Osaka, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/00 (2006.01); A61K 31/4418 (2006.01); A61K 31/496 (2006.01); A61K 31/519 (2006.01); A61K 39/395 (2006.01); A61P 27/02 (2006.01); A61P 27/06 (2006.01); C07K 16/22 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 31/4418 (2013.01); A61K 31/496 (2013.01); A61P 27/02 (2018.01); C07K 16/22 (2013.01); C07K 16/2863 (2013.01); C07K 2317/54 (2013.01); C07K 2317/55 (2013.01); C07K 2317/56 (2013.01); C07K 2317/622 (2013.01); C07K 2317/626 (2013.01);
Abstract
The present invention relates to a retinal ganglion cell death suppressor comprising a BMPR signal transduction inhibitor, a drug comprising a BMPR signal transduction inhibitor for protecting retinal neurons, and a pharmaceutical composition using these for preventing or treating a disease involving retinal ganglion cell death, such as glaucoma, diabetic retinopathy and retinal vascular occlusion.